Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Nrf2-IN-1 is an inhibitor of nuclear factor erythroid 2-related factor 2 (Nrf2).1 It inhibits Nrf2 transcriptional activity in a reporter assay using HeLa cells at 5 and 10 µM and reduces the expression of the Nrf2 target genes heme oxygenase-1 (HO-1) and glutamate-cysteine ligase modifier subunit (GCLM) in the same cells. Nrf2-IN-1 (10 µM) reduces Nrf2 protein levels in THP-1, HL-60, and U937 leukemia cells. It also reduces the growth of THP-1, HL-60, and U937 cells (IC50s = 5.33, 8.94, and 8.98 µM, respectively) and induces apoptosis in the same cells. Nrf2-IN-1 inhibits angiogenesis in a chorioallantoic membrane (CAM) assay.
WARNING This product is not for human or veterinary use.
1. Discovery of a novel Nrf2 inhibitor that induces apoptosis of human acute myeloid leukemia cells. Oncotarget 8(5), 7625-7636 (2017).